Fabryfacts.com is intended for United States Healthcare Professionals Only. If you are person living with Fabry disease, visit the patient website at www.FabryConnect.com.
close

Dear Fabry Community,
During this challenging time with the global COVID-19 outbreak, it is all the more important we look out for and support one another. The safety and welfare of families affected by rare diseases always has been and continues to be Amicus’ number one priority. Our commitment to the rare disease community will continue and we are only a phone call or email away. For questions or support, we can be reached at patientadvocacy@amicusrx.com or toll-free in the US at 1(866) 9-AMICUS (926-4287). NP-NN-ALL-00020520

Understanding the
Complexities of Fabry Disease

Fabry disease is a progressive, multisystemic, X-linked lysosomal disorder caused by mutations in the galactosidase alpha gene (GLA).1,2 Fabry disease has a wide spectrum of symptoms that may present differently in each affected individual, and can be a significant burden regardless of presentation.1,2

Read More
INTERACTIVE ORGAN MAP

Learn About the Effects
of Fabry Disease

See how Fabry disease can affect
the various organ systems.

View Now
GENOTYPES AND PHENOTYPES

See Patient Case Examples

Learn how Fabry disease can be
experienced differently by each individual.

View Now
FabryFacts.com is committed to providing information and resources about Fabry disease to support healthcare professionals in diagnosing and caring for patients with Fabry disease.

References:

  1. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138(4):338-346.
  2. Mehta A, Beck M, Eyskens F, et al. Fabry disease: a review of current management strategies. QJM. 2010;103(9):641-659.
  3. Wanner C, Arad M, Baron R, et al. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018;124(3):189-203.
  4. Mehta A, Clarke JT, Giugliani R, et al. Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet. 2009;46(8):548-552.